Acid ceramidase as a therapeutic target in metastatic prostate cancer. - Wikidata - awgldk - TriplyDB

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

http://www.wikidata.org/entity/Q36754783

about

Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.Re-configuration of sphingolipid metabolism by oncogenic transformation.Recognition Code of ZNF191(243-368) and Its Interaction with DNA Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION Altered endosome biogenesis in prostate cancer has biomarker potential.Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis.Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells.The Arabidopsis ceramidase AtACER functions in disease resistance and salt tolerance.Monascus purpureus induced apoptosis on gastric cancer cell by scavenging mitochondrial reactive oxygen species.Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.A fluorescent probe for imaging symmetric and asymmetric cell division in neurosphere formation.

P2860

Q28084270-B2079F2D-A781-4D4F-90DB-E5D995ACB7CD Q30252512-4AA54C86-EE2F-4E87-ADEB-500E08B7CC51 Q30300370-07A253B6-C500-4EAF-AC8B-14D2E25AD81B Q33649823-E472F71B-2BFD-4356-BB88-EEF3EEDC20C8 Q36118929-975461BC-A3FC-4147-BBDE-FBEF15CA02F8 Q36518353-BE37E331-126A-4963-91E6-A5BC547AC264 Q36591621-E5AE9F97-C47A-42C2-BDC0-07A7948E2268 Q37502782-219323E8-264A-4501-AE53-68726FA22AE4 Q38831997-05CEDCA4-47F9-4E05-895D-35DD3F9CB201 Q38889429-552E5458-54EB-4B1A-BF00-B9C925C83418 Q40091584-FCFF28C0-24E4-4F63-84BE-32AFE3E8111F Q41530002-7AFE1E5F-FD64-4642-81FD-1D4894EFF717 Q46248313-9D48F0DC-C2F4-4431-9295-CA5E768EBB75 Q47224220-D6DB2C7B-C900-4358-BDE6-755D10601C2A Q53045937-7A4792C2-4BB9-4DAF-8C9B-102A8A7F672F

P2860

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

http://www.wikidata.org/entity/Q36754783

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

@ast

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

@en

type

label

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

@ast

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

@en

prefLabel

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

@ast

Acid ceramidase as a therapeutic target in metastatic prostate cancer.

@en

P1433

Q36754783-4838E1AA-A9D9-4933-B0E3-24BBCE8D0A47

P1476

Q36754783-66565916-D7E5-400B-9038-6BABDA4EB64A

P2093

Q36754783-2B22317C-685B-443B-89B6-A723CF51BBF5

Q36754783-4922D2F4-F628-4C51-BEB8-53E898C00902

Q36754783-7AEB8E17-B3C0-4602-9205-C492501A00B3

Q36754783-8C006192-F033-4EE6-B94E-75DEE392927E

Q36754783-AD9E1487-1C7C-497B-97F6-510E40EE4D2E

Q36754783-AF6343E9-5883-4730-A3F2-4B4CD5159F23

Q36754783-B136CE4C-CC37-45DC-963D-7FADBDD9B4C1

Q36754783-C8361712-51BC-4495-8379-17F0AB07B486

Q36754783-E2BBE3E2-5536-4052-BEDF-668548035FB1

Q36754783-F9B524DA-8062-407F-A96F-BCB8F72218F2

P2860

Q36754783-039D14EF-BF0C-42E2-9614-89C7012E7170

Q36754783-041A94E4-1A5F-4F3D-8696-99ADA8237A80

Q36754783-05838377-5E2F-4297-BF2C-8B856A12C309

Q36754783-07729C8C-0E71-4077-A29E-A8F3AB51158F

Q36754783-0B282FAA-7200-4D6A-9401-A37B076108D2

Q36754783-14EA3E54-59C5-4B0E-869C-6F5C086087F8

Q36754783-170D3005-939F-4713-8E26-97A257853F7B

Q36754783-18C04206-D638-4F4D-BF2C-423D6AFEBF5F

Q36754783-1CD934E0-8AF0-45B8-8AF4-94FD8F2A350A

Q36754783-1D8251D3-3688-49D6-BDAF-5438E5F5A703

P304

Q36754783-8F1163B8-F738-4D8C-8BD5-6AE27644B1D6

P31

Q36754783-2B67DBEC-8B61-4124-8D76-8394754DF5F2

P356

Q36754783-0DFE53AB-2E5B-40AE-8EF5-CAD590E7D784

P433

Q36754783-E2FDCE9A-40C0-4B18-8ECD-49116D4C39A8

P478

Q36754783-DDFE4836-CE80-49E8-97AF-162FC89BB183

P50

Q36754783-1C9CCA15-1FAB-4EB5-9ADE-EF2A0E7A6388

Q36754783-5481A6F5-4B4D-473F-80B4-2FC5BCEFF57A

Q36754783-9C61D0A7-B1BC-4CC3-B8B2-539594D8CA4C

Q36754783-AA100BCA-EAD2-40CF-BE53-81A0CB15EB01

Q36754783-DC4DFBF4-C182-42E0-868B-72554CE5FD2C

P577

Q36754783-ECD3C84F-4B1C-4F25-B0F4-E379B95F2BBE

P5875

Q36754783-182C51F5-B5A4-41BB-857F-80566E0985C8

P698

Q36754783-34A068AB-90DB-4026-9076-9C9C7A975CD8

P932

Q36754783-D3D5ABC2-3F69-469D-8984-1211D95B8BCE

P356

P1433

Journal of Lipid Research

P1476

Acid ceramidase as a therapeutic target in metastatic prostate cancer

@en

P2093

Alba Díaz

http://www.w3.org/2001/XMLSchema#string

Antonio Delgado

http://www.w3.org/2001/XMLSchema#string

Francesca Cingolani

http://www.w3.org/2001/XMLSchema#string

Josefina Casas

http://www.w3.org/2001/XMLSchema#string

José Luis Abad

http://www.w3.org/2001/XMLSchema#string

Oscar Meca-Cortés

http://www.w3.org/2001/XMLSchema#string

Pedro L Fernández

http://www.w3.org/2001/XMLSchema#string

Raquel Bermudo

http://www.w3.org/2001/XMLSchema#string

Simón García

http://www.w3.org/2001/XMLSchema#string

Timothy M Thomson

http://www.w3.org/2001/XMLSchema#string

P2860

Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis

Human acid ceramidase is overexpressed but not mutated in prostate cancer

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.

A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases

Estimates of cancer incidence and mortality in Europe in 2008.

Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity

Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine.

P304

1207-1220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M032375

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Jerónimo Blanco

Toni Celià-Terrassa

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235670097

http://www.w3.org/2001/XMLSchema#string

P698

23423838

http://www.w3.org/2001/XMLSchema#string

P932

3622318

http://www.w3.org/2001/XMLSchema#string